Clinical trial
Prebiotics in the Prevention of Necrotizing Enterocolitis
NCT00437567 · Shaare Zedek Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00437567 |
|---|---|
| Title | Prebiotics in the Prevention of Necrotizing Enterocolitis |
| Official title | Prebiotics vs. Placebo in the Prevention of Necrotizing Enterocolitis in Premature Neonates |
| Lead sponsor | Shaare Zedek Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Necrotizing Enterocolitis |
| Intervention type | Dietary Supplement, Other |
| Interventions | Galacto-oligosaccharide (GOS), Placebo |
| Enrollment | 260 |
| Start date | Jul 1, 2009 |
| Primary completion | Jul 1, 2014 |
| Completion | Jul 1, 2014 |
| First posted | Feb 21, 2007 |
| Last update posted | Jan 3, 2014 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: